4
Changes in Ownership
Structure Therapeutics Inc. Filed Acc 0001801842-26-000002
Chief Development Officer gave up 4,836 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Hall Ashley · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-03 | Shares withheld for taxes : show line 1 in the form | −4,836 | $20.99 | $101,508 | 107,481 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-20 | Grant or award : show line 2 in the form American Depositary Shares | +225 | 225 | D |
| 2025-11-20 | Grant or award : show line 3 in the form American Depositary Shares | +237 | 462 | D |
Loading xslF345X05/form4-03052026_060304.xml…